The DOI matches its Crossref record; 62 of the 62 references it cites were found in a registry or an index.
Accumulation of amyloid precursor protein in the mitochondrial import channels of human Alzheimer's disease brain is associated with mitochondrial dysfunction
Open accessAbstract
Mitochondrial dysfunction is one of the major intracellular lesions of Alzheimer's disease (AD). However, the causative factors involved in the mitochondrial dysfunction in human AD are not well understood. Here we report that nonglycosylated full-length and C-terminal truncated amyloid precursor protein (APP) accumulates exclusively in the protein import channels of mitochondria of human AD brains but not in age-matched controls. Furthermore, in AD brains, mitochondrially associated APP formed stable approximately 480 kDa complexes with the translocase of the outer mitochondrial membrane 40 (TOM40) import channel and a super complex of approximately 620 kDa with both mitochondrial TOM40 and the translocase of the inner mitochondrial membrane 23 (TIM23) import channel TIM23 in an "N(in mitochondria)-C(out cytoplasm)" orientation. Accumulation of APP across mitochondrial import channels, which varied with the severity of AD, inhibited the entry of nuclear-encoded cytochrome c oxidase subunits IV and Vb proteins, which was associated with decreased cytochrome c oxidase activity and increased levels of H2O2. Regional distribution of mitochondrial APP showed higher levels in AD-vulnerable brain regions, such as the frontal cortex, hippocampus, and amygdala. Mitochondrial accumulation of APP was also observed in the cholinergic, dopaminergic, GABAergic, and glutamatergic neuronal types in the category III AD brains. The levels of translocationally arrested mitochondrial APP directly correlated with mitochondrial dysfunction. Moreover, apolipoprotein genotype analysis revealed that AD subjects with the E3/E4 alleles had the highest content of mitochondrial APP. Collectively, these results suggest that abnormal accumulation of APP across mitochondrial import channels, causing mitochondrial dysfunction, is a hallmark of human AD pathology.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“accumulating data certainly do suggest APP and Aβ, as well as the entire γ-secretase complex, physically associate with mitochondria and can effect changes in mitochondrial function [58-67].”
From The Alzheimer’s disease mitochondrial cascade hypothesis: progress and perspectives (2014) · cites this paper as [63]
In the citing paper
“APP blocked mitochondrial import machinery and impaired mitochondrial function in AD brain by forming a complex with translocases of the inner and outer mitochondrial membranes.204”
From Amyloid β-based therapy for Alzheimer’s disease: Challenges, successes and future (2023) · cites this paper as [204]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
PROTEIN MEASUREMENT WITH THE FOLIN PHENOL REAGENT
Lowry, O. H., Rosebrough, N., Farr, A. L., & Randall, R. (1951) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)52451-6 · Cited by 316,394
Blue native electrophoresis for isolation of membrane protein complexes in enzymatically active form
Schägger, H., & von JAGOW, G. (1991) · Analytical Biochemistry · doi:10.1016/0003-2697(91)90094-a · Cited by 2,267
The cholinergic hypothesis of Alzheimer’s disease: A review of progress
Francis, P. T., Palmer, A. M., Snape, M., & Wilcock, G. K. (1999) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.66.2.137 · Cited by 2,198 · cited 1×
“In addition to cholinergic neurons, several other neuronal types, such as dopaminergic, GABAergic, and glutamatergic neurons, have been shown to be affected in the later stages of the pathogenesis of AD (Francis et al., 1999; Francis, 2003).”
BackgroundCopper, iron and zinc in Alzheimer's disease senile plaques
Lovell, M. A., Robertson, J. D., Teesdale, W. J., Campbell, J. L., & Markesbery, W. R. (1998) · Journal of the Neurological Sciences · doi:10.1016/s0022-510x(98)00092-6 · Cited by 2,120
HYMAN, B. T., & TROJANOWSKI, J. Q. (1997) · Journal of Neuropathology and Experimental Neurology · doi:10.1097/00005072-199710000-00002 · Cited by 1,542
Cherny, R. A., Atwood, C. S., Xilinas, M. E., Gray, D. N., Jones, W. D., McLean, C. A., Barnham, K. J., Volitakis, I., Fraser, F. W., Kim, Y.-S., et al. (2001) · Neuron · doi:10.1016/s0896-6273(01)00317-8 · Cited by 1,447
Mitochondrial abnormalities in Alzheimer's disease
Hirai, K., Aliev, G., Nunomura, A., Fujioka, H., Russell, R. L., Atwood, C. S., Johnson, A. B., Kress, Y., Vinters, H. V., Tabaton, M., et al. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-09-03017.2001 · Cited by 1,367
Translating cell biology into therapeutic advances in Alzheimer's disease
Selkoe, D. J. (1999) · Nature · doi:10.1038/399a023 · Cited by 1,166
Manczak, M., Anekonda, T. S., Henson, E., Park, B. S., Quinn, J., & Reddy, P. H. (2006) · Human Molecular Genetics · doi:10.1093/hmg/ddl066 · Cited by 1,104
Consensus Recommendations for the Postmortem Diagnosis of Alzheimer’s Disease
(1997) · Neurobiology of Aging · doi:10.1016/s0197-4580(97)00057-2 · Cited by 981
Mitochondria take center stage in aging and neurodegeneration
Beal, M. F. (2005) · Annals of Neurology · doi:10.1002/ana.20624 · Cited by 957
Mitochondrial Aβ: a potential focal point for neuronal metabolic dysfunction in Alzheimer's disease
Caspersen, C., Wang, N., Yao, J., Sosunov, A., Chen, X., Lustbader, J. W., Xu, H. W., Stern, D., McKhann, G., & Du Yan, S. (2005) · The FASEB Journal · doi:10.1096/fj.05-3735fje · Cited by 738
Characterization of the human heart mitochondrial proteome
Taylor, S. W., Fahy, E., Zhang, B., Glenn, G. M., Warnock, D. E., Wiley, S. E., Murphy, A. N., Gaucher, S. P., Capaldi, R., Gibson, B. W., et al. (2003) · Nature Biotechnology · doi:10.1038/nbt793 · Cited by 702
Cytochrome oxidase deficiency in Alzheimer’s disease
Parker, W. D., Filley, C. M., & Parks, J. K. (1990) · Neurology · doi:10.1212/wnl.40.8.1302 · Cited by 598 · cited 1×
“Altered mitochondrial fluidity and the activity of mitochondrial cytochrome c oxidase, which is the terminal oxidase in the respiratory chain, have been reported to be low in the AD brains (Parker, 1991; Sims, 1996; Maurer et al., 2000).”
BackgroundMUTANT GENES IN FAMILIAL ALZHEIMER'S DISEASE AND TRANSGENIC MODELS
Price, D. L., & Sisodia, S. S. (1998) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.21.1.479 · Cited by 581
Anandatheerthavarada, H. K., Biswas, G., Robin, M.-A., & Avadhani, N. G. (2003) · The Journal of Cell Biology · doi:10.1083/jcb.200207030 · Cited by 571
A selective defect of cytochrome c oxidase is present in brain of Alzheimer disease patients
Maurer, I. (2000) · Neurobiology of Aging · doi:10.1016/s0197-4580(00)00112-3 · Cited by 475
Selkoe (1999) · doi:10.1038/19866 · Cited by 468
Mańczak, M., Park, B. S., Jung, Y., & Reddy, P. H. (2004) · NeuroMolecular Medicine · doi:10.1385/nmm:5:2:147 · Cited by 434
Busciglio, J., Pelsman, A., Wong, C., Pigino, G., Yuan, M., Mori, H., & Yankner, B. A. (2002) · Neuron · doi:10.1016/s0896-6273(02)00604-9 · Cited by 387
The role of metals in neurodegenerative processes: aluminum, manganese, and zinc
Zatta, P. F., Lucchini, R. G., van Rensburg, S. J., & Taylor, A. (2003) · Brain Research Bulletin · doi:10.1016/s0361-9230(03)00182-5 · Cited by 344
Intraneuronal Aβ accumulation and origin of plaques in Alzheimer's disease
Gouras, G. K., Almeida, C. G., & Takahashi, R. H. (2005) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2005.05.022 · Cited by 338
Copper-Dependent Inhibition of Human Cytochrome c Oxidase by a Dimeric Conformer of Amyloid-β1-42
Crouch, P. J., Blake, R., Duce, J. A., Ciccotosto, G. D., Li, Q.-X., Barnham, K. J., Curtain, C. C., Cherny, R. A., Cappai, R., Dyrks, T., et al. (2005) · The Journal of Neuroscience · doi:10.1523/jneurosci.4276-04.2005 · Cited by 327
Dekker, P., Martin, F., Maarse, A. C., Bömer, U., Müller, H., Guiard, B., Meijer, M., Rassow, J., & Pfanner, N. (1997) · The EMBO Journal · doi:10.1093/emboj/16.17.5408 · Cited by 305
Are mitochondria critical in the pathogenesis of Alzheimer's disease?
Reddy, P. H., & Beal, M. F. (2005) · Brain Research Reviews · doi:10.1016/j.brainresrev.2005.03.004 · Cited by 294
Amyloid β-induced Changes in Nitric Oxide Production and Mitochondrial Activity Lead to Apoptosis
Keil, U., Bonert, A., Marques, C. A., Scherping, I., Weyermann, J., Strosznajder, J. B., Müller-Spahn, F., Haass, C., Czech, C., Pradier, L., et al. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m405600200 · Cited by 287
Brain aluminum in aging and Alzheimer disease
MCDERMOTT, J. R., Smith, A. I., Iqbal, K., & Wı́sniewski, H. M. (1979) · Neurology · doi:10.1212/wnl.29.6.809 · Cited by 263
Glutamatergic systems in Alzheimer's disease
Francis, P. T. (2003) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.934 · Cited by 255
The βA4 amyloid precursor protein binding to copper
Hesse, L., Beher, D., Masters, C. L., & Multhaup, G. (1994) · FEBS Letters · doi:10.1016/0014-5793(94)00658-x · Cited by 247
Valla, J. E., Berndt, J. D., & Gonzalez-Lima, F. (2001) · Journal of Neuroscience · doi:10.1523/jneurosci.21-13-04923.2001 · Cited by 241
Increased regional brain concentrations of ceruloplasmin in neurodegenerative disorders
Loeffler, D. A., LeWitt, P. A., Juneau, P. L., Sima, A. A. F., Nguyen, H.-U., DeMaggio, A. J., Brickman, C. M., Brewer, G. J., Dick, R. D., Troyer, M. D., et al. (1996) · Brain Research · doi:10.1016/s0006-8993(96)00782-2 · Cited by 237
Metals and trace elements in plasma and cerebrospinal fluid in normal aging and Alzheimer's disease.
Basun, H., Forssell, L. G., Wetterberg, L., & Winblad, B. G. (1991) · PubMed · Cited by 228
Prabu, S. K., Anandatheerthavarada, H. K., Raza, H., Srinivasan, S., Spear, J. F., & Avadhani, N. G. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m507741200 · Cited by 190
Single translation—dual destination: mechanisms of dual protein targeting in eukaryotes
Karniely, S., & Pines, O. (2005) · EMBO Reports · doi:10.1038/sj.embor.7400394 · Cited by 172
Bussière, T., Bard, F., Barbour, R., Grajeda, H., Guido, T., Khan, K., Schenk, D., Games, D., Seubert, P. A., & Buttini, M. (2004) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)63360-3 · Cited by 170
Molecular Genetics of Late‐Onset Alzheimer's Disease
Kamboh, M. I. (2004) · Annals of Human Genetics · doi:10.1046/j.1529-8817.2004.00110.x · Cited by 170
Differential involvement of protein kinase C isozymes in Alzheimer's disease
Masliah, E., Cole, G. M., Shimohama, S., Hansen, L. A., DeTeresa, R. M., Terry, R. D., & Saitoh, T. (1990) · Journal of Neuroscience · doi:10.1523/jneurosci.10-07-02113.1990 · Cited by 165
Shaping the mitochondrial proteome
Gabaldón, T., & Huynen, M. A. (2004) · Biochimica et Biophysica Acta (BBA) - Bioenergetics · doi:10.1016/j.bbabio.2004.07.011 · Cited by 156
Presenilin function and γ‐secretase activity
Brunkan, A. L., & Goate, A. (2005) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2005.03099.x · Cited by 149
Addya, S., Anandatheerthavarada, H. K., Biswas, G., Bhagwat, S. V., Mullick, J., & Avadhani, N. G. (1997) · The Journal of Cell Biology · doi:10.1083/jcb.139.3.589 · Cited by 137
Anandatheerthavarada, H. K., Biswas, G., Mullick, J., Sepuri, N. B. V., Otvos, L., Pain, D., & Avadhani, N. G. (1999) · The EMBO Journal · doi:10.1093/emboj/18.20.5494 · Cited by 132
Mitochondrial failures in Alzheimer's disease
Zhu, X., Smith, M. A., Perry, G. L., & Aliev, G. (2004) · American Journal of Alzheimer s Disease & Other Dementias® · doi:10.1177/153331750401900611 · Cited by 125
Apolipoprotein E: a major piece in the Alzheimer's disease puzzle
Cedazo-Mı́nguez, Á., & Cowburn, R. F. (2001) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2001.tb00159.x · Cited by 123
Nitrogen disruption of synaptoneurosomes: an alternative method to isolate brain mitochondria
Brown, M. R., Sullivan, P. G., Dorenbos, K., Modafferi, E. F., Geddes, J. W., & Steward, O. (2004) · Journal of Neuroscience Methods · doi:10.1016/j.jneumeth.2004.02.028 · Cited by 114
Robin, M., Prabu, S. K., Raza, H., Anandatheerthavarada, H. K., & Avadhani, N. G. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m301807200 · Cited by 107
Moro, F., Sirrenberg, C., Schneider, H., Neupert, W., & Brunner, M. (1999) · The EMBO Journal · doi:10.1093/emboj/18.13.3667 · Cited by 103
Duan, W., Rangnekar, V. M., & Mattson, M. P. (1999) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1999.0722312.x · Cited by 97
Alzheimers Disease: Interactions Between Cholinergic Functions and β- amyloid
Yan, Z., & Feng, J. (2004) · Current Alzheimer Research · doi:10.2174/1567205043331992 · Cited by 84
Cytochrome Oxidase Deficiency in Alzheimer's Diseasea
Parker, W. D. (1991) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1991.tb00191.x · Cited by 79
Zhu, Y., & Hui, D. Y. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m303171200 · Cited by 72
Familial Alzheimer's disease: Site of mutation influences clinical phenotype
Lippa, C. F., Swearer, J. M., Kane, K., Nochlin, D., Bird, T. D., Ghetti, B. F., Nee, L. E., George‐Hyslop, P. S., Pollen, D. A., & Drachman, D. A. (2000) · Annals of Neurology · doi:10.1002/1531-8249(200009)48:3 · Cited by 67
Periz, G., & Fortini, M. (2004) · Journal of Neuroscience Research · doi:10.1002/jnr.20203 · Cited by 65
Cada, A. M., Gonzalez-Lima, F., Rose, G. M., & Bennett, M. C. (1995) · Metabolic Brain Disease · doi:10.1007/bf02109361 · Cited by 58
Cedazo-Mı́nguez, A., Wiehager, B., Winblad, B., Hüttinger, M., & Cowburn, R. F. (2001) · Neurochemistry International · doi:10.1016/s0197-0186(00)00128-5 · Cited by 50
Effects of learning on cytochrome oxidase activity in cuttlefish brain
Agin, V., Chichery, R., & Chichery, M. (2001) · Neuroreport · doi:10.1097/00001756-200101220-00030 · Cited by 48
Energy metabolism, oxidative stress and neuronal degeneration in Alzheimer’s disease
Sims, N. R. (1996) · Neurodegeneration · doi:10.1006/neur.1996.0059 · Cited by 45 · cited 2×
“Mitochondrial dysfunction may play a role in the degeneration/cell death of neurons during the pathogenesis of AD (Sims, 1996; Zhu et al., 2004).”
BackgroundBerndt, J. D., Callaway, N. L., & Gonzalez-Lima, F. (2001) · Journal of Toxicology and Environmental Health · doi:10.1080/152873901750128380 · Cited by 41
Transport of proteins into mitochondria
Truscott, K. N., Pfanner, N., & Voos, W. (2007) · Springer eBooks · doi:10.1007/bfb0115593 · Cited by 41
Montemurro, D. G., & Bruni, J. (1981) · Medical Entomology and Zoology · Cited by 39
Vijayasarathy, C., Damle, S., Lenka, N., & Avadhani, N. G. (1999) · European Journal of Biochemistry · doi:10.1046/j.1432-1327.1999.00843.x · Cited by 38
Protein kinase C activity and protein levels in Alzheimer's disease.
Lanius, R. A., Wagey, R., Sahl, B., Beattie, B., Feldman, H., Pelech, S., & Krieger, C. (1997) · Brain Research · doi:10.1016/s0006-8993(97)00422-8 · Cited by 19
Flagged first, then by citations
Research works printed but not linked: 2
- Dasso M (1998) in Current protocols in cell biology, In vitro reconstitution, eds Bonifacino JS Dasso M Harford JB Lippincot-Schawartz J Yamada KM (Wiley, New York), pp 11.0.1–11.0.2.
- Jagannatha Rao, 1999, Trace elements in the cerebrospinal fluid of Alzheimer’s disease, Alzheimers Rep, 2, 333
Cited by
Sorted by citations
Amyloid Beta: Structure, Biology and Structure-Based Therapeutic Development
Chen, G.-F., Xu, T.-H., Yan, Y., Zhou, Y.-R., Jiang, Y., Melcher, K., & Xu, H. E. (2017) · Acta Pharmacologica Sinica · doi:10.1038/aps.2017.28 · Cited by 1,965
Fang, E. F., Hou, Y., Palikaras, K., Adriaanse, B. A., Kerr, J. S., Yang, B., Lautrup, S., Hasan-Olive, M. M., Caponio, D., Dan, X., et al. (2019) · Nature Neuroscience · doi:10.1038/s41593-018-0332-9 · Cited by 1,740
Mitochondria dysfunction in the pathogenesis of Alzheimer’s disease: Recent advances.
Wang, W., Zhao, F., Ma, X., Perry, G., & Zhu, X. (2020) · Molecular Neurodegeneration · doi:10.1186/s13024-020-00376-6 · Cited by 1,274
Multi-target-Directed Ligands To Combat Neurodegenerative Diseases
Cavalli, A., Bolognesi, M. L., Minarini, A., Rosini, M., Tumiatti, V., Recanatini, M., & Melchiorre, C. (2008) · Journal of Medicinal Chemistry · doi:10.1021/jm7009364 · Cited by 1,152
Devi, L., Raghavendran, V., Prabhu, B. M., Avadhani, N. G., & Anandatheerthavarada, H. K. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m710012200 · Cited by 1,127
Metadata
- Authors
- Devi, L., Prabhu, B. M., Galati, D. F., Avadhani, N. G., & Anandatheerthavarada, H. K.
- Affiliations
- University of Pennsylvania (US)
- Venue
- The Journal of Neuroscience
- Publisher
- Society for Neuroscience
- Published
- 2006-08-30
- Volume
- 26
- Issue
- 35
- Pages
- 9057-9068
- ISSN
- 0270-6474 (ISSN-L)
- 1529-2401
- PMC
- PMC6675337
- OpenAlex
- W2076241970
- Cited by
- 792
- References
- 62
- Citations by year
- 2026: 21 · 2025: 21 · 2024: 36 · 2023: 47 · 2022: 53 · 2021: 60 · 2020: 50 · 2019: 37 · 2018: 44 · 2017: 39 · 2016: 36 · 2015: 35 · 2014: 34 · 2013: 40 · 2012: 50
- FWCI
- 19.78
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Journal of Neuroscience (publishedVersion, cc-by-nc-sa)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health
- National Institute on Aging (R01AG021920, AG 021920)
- National Institute of General Medical Sciences (GM-49683, R01GM049683)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Mitochondrial Function and Pathology
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Keywords
- amyloid precursor protein, Alzheimer's disease, mitochondrial dysfunction, Tom40, Tim23, cytochrome c oxidase, hydrogen peroxide, neuronal cell types
- MeSH terms
- Alzheimer Disease, Apolipoproteins E, Biological Transport, Brain, Cadaver, Electron Transport Complex IV, Glycosylation, Humans, Hydrogen Peroxide, Mitochondria, Neurons, Tissue Distribution, Case-Control Studies, Amyloid beta-Protein Precursor, Mitochondrial Proteins, Mitochondrial Membrane Transport Proteins, Mitochondrial Membranes, Apolipoprotein E3, Apolipoprotein E4
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review